CINCINNATI--(BUSINESS WIRE)-- Aerpio Pharmaceuticals, Inc. (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results